CME Valuation
| MX4A Stock | EUR 228.75 0.10 0.04% |
At this time, the firm appears to be undervalued. CME Group shows a prevailing Real Value of €261.05 per share. The current price of the firm is €228.75. Our model approximates the value of CME Group from examining the firm fundamentals such as Profit Margin of 0.54 %, current valuation of 60.85 B, and Return On Equity of 0.0992 as well as evaluating its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that CME's price fluctuation is very steady at this time. Calculation of the real value of CME Group is based on 3 months time horizon. Increasing CME's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the CME stock is determined by what a typical buyer is willing to pay for full or partial control of CME Group. Since CME is currently traded on the exchange, buyers and sellers on that exchange determine the market value of CME Stock. However, CME's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 228.75 | Real 261.05 | Hype 228.75 | Naive 226.87 |
The real value of CME Stock, also known as its intrinsic value, is the underlying worth of CME Group Company, which is reflected in its stock price. It is based on CME's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of CME's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of CME Group helps investors to forecast how CME stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of CME more accurately as focusing exclusively on CME's fundamentals will not take into account other important factors: CME Total Value Analysis
CME Group is now forecasted to have takeover price of 60.85 B with market capitalization of 62.87 B, debt of 3.42 B, and cash on hands of 1.02 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the CME fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
60.85 B | 62.87 B | 3.42 B | 1.02 B |
CME Investor Information
About 88.0% of the company shares are owned by institutional investors. The book value of CME was now reported as 74.89. The company recorded earning per share (EPS) of 6.98. CME Group last dividend was issued on the 9th of March 2023. Based on the measurements of operating efficiency obtained from CME's historical financial statements, CME Group is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.CME Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. CME has an asset utilization ratio of 2.88 percent. This implies that the Company is making €0.0288 for each dollar of assets. An increasing asset utilization means that CME Group is more efficient with each dollar of assets it utilizes for everyday operations.CME Ownership Allocation
CME holds a total of 359.72 Million outstanding shares. The majority of CME Group outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in CME Group to benefit from reduced commissions. Thereupon, institutional investors are subject to a different set of regulations than regular investors in CME. Please pay attention to any change in the institutional holdings of CME Group as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.CME Profitability Analysis
The company reported the revenue of 5.02 B. Net Income was 2.69 B with profit before overhead, payroll, taxes, and interest of 5.01 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates CME's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in CME and how it compares across the competition.
About CME Valuation
The stock valuation mechanism determines CME's current worth on a weekly basis. Our valuation model uses a comparative analysis of CME. We calculate exposure to CME's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of CME's related companies.CME Group Inc., through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. CME Group Inc. was founded in 1898 and is headquartered in Chicago, Illinois. CME GROUP operates under Financial Exchanges classification in Germany and is traded on Frankfurt Stock Exchange. It employs 4590 people.
8 Steps to conduct CME's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates CME's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct CME's valuation analysis, follow these 8 steps:- Gather financial information: Obtain CME's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine CME's revenue streams: Identify CME's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research CME's industry and market trends, including the size of the market, growth rate, and competition.
- Establish CME's growth potential: Evaluate CME's management, business model, and growth potential.
- Determine CME's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate CME's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for CME Stock analysis
When running CME's price analysis, check to measure CME's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CME is operating at the current time. Most of CME's value examination focuses on studying past and present price action to predict the probability of CME's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CME's price. Additionally, you may evaluate how the addition of CME to your portfolios can decrease your overall portfolio volatility.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stocks Directory Find actively traded stocks across global markets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |